Literature DB >> 6667675

The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells.

C Blaineau, J Le Pendu, D Arnaud, F Connan, P Avner.   

Abstract

Monoclonal antibody 75.12 raised against the human ovarian teratocarcinoma cell line PA1 detects a 'Y' or iso-leb glycosidic structure. Using the 75.12 antibody we have established that the Y antigen is expressed on some but not all mouse embryonal carcinoma (EC) lines. The Y or 75.12 antigen-positive EC cell lines F9 and PCC4 cease to express the antigen after differentiation induced with retinoic acid and this decreased expression parallels the morphological differentiation of the EC cells. These results support not only the idea that carbohydrate structures present on embryonic cells undergo marked alteration during differentiation, but also that established mouse EC cells may differ in their differentiation states.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667675      PMCID: PMC555437          DOI: 10.1002/j.1460-2075.1983.tb01726.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  [Mouse teratocarcinoma: differentiation in cultures of a multipotential primitive cell line (author's transl)].

Authors:  J F Nicolas; P Dubois; H Jakob; J Gaillard; F Jacob
Journal:  Ann Microbiol (Paris)       Date:  1975-01

2.  A procedure for removing red cells and dead cells from lymphoid cell suspensions.

Authors:  W F Davidson; C R Parish
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

3.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

4.  Similar location of an early embryonic antigen on mouse and human spermatozoa.

Authors:  M Fellous; G Gachelin; M H Buc-Caron; P Dubois; F Jacob
Journal:  Dev Biol       Date:  1974-12       Impact factor: 3.582

5.  The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro.

Authors:  R A Pattillo; G O Gey
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

6.  Cultivation in vitro of cells derived from a human rhabdomyosarcoma.

Authors:  R M McAllister; J Melnyk; J Z Finkelstein; E C Adams; M B Gardner
Journal:  Cancer       Date:  1969-09       Impact factor: 6.860

7.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

8.  Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma.

Authors:  J M Lehman; W C Speers; D E Swartzendruber; G B Pierce
Journal:  J Cell Physiol       Date:  1974-08       Impact factor: 6.384

9.  Alkaline phosphatase activity in mouse teratoma.

Authors:  E G Berstine; M L Hooper; S Grandchamp; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains.

Authors:  J A Levy
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

View more
  3 in total

Review 1.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

2.  Differential Hm antigen expression on EC cells and early differentiated derivatives.

Authors:  M C Simmler; P R Avner
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

3.  Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitope.

Authors:  M Schwonzen; R Schmits; S E Baldus; M Vierbuchen; F G Hanisch; M Pfreundschuh; V Diehl; J Bara; G Uhlenbruck
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.